21
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Multiple Criteria Decision Analysis for Health Care Decision Making--An Introduction: Report 1 of the ISPOR MCDA Emerging Good Practices Task Force.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Health care decisions are complex and involve confronting trade-offs between multiple, often conflicting, objectives. Using structured, explicit approaches to decisions involving multiple criteria can improve the quality of decision making and a set of techniques, known under the collective heading multiple criteria decision analysis (MCDA), are useful for this purpose. MCDA methods are widely used in other sectors, and recently there has been an increase in health care applications. In 2014, ISPOR established an MCDA Emerging Good Practices Task Force. It was charged with establishing a common definition for MCDA in health care decision making and developing good practice guidelines for conducting MCDA to aid health care decision making. This initial ISPOR MCDA task force report provides an introduction to MCDA - it defines MCDA; provides examples of its use in different kinds of decision making in health care (including benefit risk analysis, health technology assessment, resource allocation, portfolio decision analysis, shared patient clinician decision making and prioritizing patients' access to services); provides an overview of the principal methods of MCDA; and describes the key steps involved. Upon reviewing this report, readers should have a solid overview of MCDA methods and their potential for supporting health care decision making.

          Related collections

          Author and article information

          Journal
          Value Health
          Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research
          1524-4733
          1098-3015
          Jan 2016
          : 19
          : 1
          Affiliations
          [1 ] School of Health and Related Research (ScHARR), University of Sheffield, Sheffield, UK. Electronic address: p.thokala@sheffield.ac.uk.
          [2 ] Office of Health Economics, London, UK.
          [3 ] Evidera, London, UK.
          [4 ] Radboud University Medical Center, Radboud Institute for Health Sciences, Nijmegen, The Netherlands.
          [5 ] National Institute for Health and Clinical Excellence (NICE), Manchester, UK.
          [6 ] Department of Health Policy and Health Economics, Eötvös Loránd University (ELTE); Syreon Research Institute, Budapest, Hungary.
          [7 ] NDA Group AB, UK and Sweden.
          [8 ] Regional Regulatory Affairs, Janssen Pharmaceutical Companies of Johnson & Johnson, Antwerp, Belgium.
          [9 ] Canadian Centre for Applied Research in Cancer Control (ARCC), British Columbia Cancer Agency, Vancouver, WA, USA; Leslie Diamond Chair in Cancer Survivorship, Simon Fraser University, Vancouver, WA, USA.
          [10 ] Formulary Development, Premera Blue Cross, Bothell, WA, USA; University of Washington, Seattle, WA, USA.
          [11 ] Department of Health Technology & Services Research, University of Twente, Enschede, The Netherlands.
          Article
          S1098-3015(15)05135-9
          10.1016/j.jval.2015.12.003
          26797229
          47549069-1f33-43fc-947c-6824c5e722af
          Copyright © 2016. Published by Elsevier Inc.
          History

          MCDA,decision making,health care,multiple criteria decision analysis

          Comments

          Comment on this article